Skip to main content

Overview

Dr. Beth McGinty is the Livingston Farrand Professor and Chief of the Division of Health Policy and Economics in the Department of Population Health Science at Weill Cornell Medicine. She conducts research focused on how health policies affect populations with complex health and social needs, including people experiencing mental illness, substance use disorder, chronic pain, and others. Her work is characterized by integrating approaches from the fields of public policy, health economics, and implementation science to understand how policies affect population health.

Highlights

  1. 1
    The New England journal of medicine · 2020
    PMID: 32242352DOIFirst author138 citations
  2. 2
    JAMA network open · 2023
    PMID: 36607641PMCID: PMC9857553DOISenior author64 citations
  3. 3
    JAMA · 2020
    PMID: 32492088PMCID: PMC7270868DOIFirst author820 citations

Publications

253 publications

Active

12 grants
  • MPI
    Integrating Medicare and Medicaid for Dual Eligibles with Disabilities: Evaluating the Impact on Utilization, Quality, Mortality, and Chronic Diseases Management
    National Institute on Aging · 2026–2031
    R01AG099343-01
  • Co-I
    Understanding the Role of Nursing Home Enforcement and Oversight in Post-Acute and Long-Stay Resident Quality of Care
    National Institute on Aging · 2026–2031
    R01AG092393-01A1
  • MPI
    The impact of peer support in treatment engagement and adverse events for Medicaid beneficiaries with substance use disorder: a mixed-methods study
    National Institute on Drug Abuse · 2025–2030
    R01DA062431-01A1
  • MPI
    Integrating Medicare and Medicaid for dual eligibles with serious mental illness: studying healthcare utilization, quality, and mortality
    National Institute of Mental Health · 2024–2029
    R01MH139215-03
  • Sub-PI
    Impact of State Cannabis Laws on Cancer Pain Management and Outcomes: A mixed-methods study
    National Cancer Institute · 2025–2029 · via University of Michigan
    R37CA291990-02
  • Sub-PI
    Center to Accelerate Translation of Interventions to Decrease Premature Mortality in Persons with Serious Mental Illness
    National Institute of Mental Health · 2022–2029 · via The Johns Hopkins University· 2 renewals
    P50MH115842-07
  • Co-I
    Data-Driven Approach to Identify Determinants of Outcomes and Risk Factors of Cardiovascular Diseases in New York City Area
    Novartis Foundation · 2023–2027
    NF 231850-01
  • Sub-PI
    Studying the Implementation and Outcomes of State Prenatal Drug Use Law
    Centers for Disease Control and Prevention · 2024–2027 · via The Johns Hopkins University
    R01CE003689-03-00
  • Sub-PI
    Achieving Cardiovascular Health Equity in Community Mental Health: Optimizing Implementation Strategies
    National Heart, Lung, and Blood Institute · 2023–2027 · via The Johns Hopkins University
    UH3HL154280-07
  • Sub-PI
    HD2A RASC-Research and Evaluation Core
    National Institute on Drug Abuse · 2022–2027 · via Stanford University
    U2CDA057717-04
  • Sub-PI
    Center for Dissemination and Implementation at Stanford (C-DIAS)
    National Institute on Drug Abuse · 2024–2027 · via Stanford University
    P50DA054072-05
  • Sub-PI
    Studying How State And Local Health Services Delivery Policies Can Mitigate The Effects Of Disasters On Drug Addiction Treatment And Overdose: A Mixed-Methods Study Of Covid-19.
    National Institute on Drug Abuse · 2022–2026 · via The Johns Hopkins University
    R01DA053232-05
Completed grants (7)
  • Sub-PI
    Studying the Effects of Corporate and Private Equity Acquisitions of Behavioral Health Treatment Facilities on Access to, Quality of, and Spending on Care for Medicare Beneficiaries in the U.S
    Commonwealth Fund · 2024–2025 · via The Johns Hopkins University
    23-23781
  • PI
    State Medical Cannabis Laws, Chronic Pain, And Opioids: A Mixed-Methods Approach
    National Institute on Drug Abuse · 2023–2025
    R01DA049789-04
  • Sub-PI
    Characterizing behavioral health mergers and acquisitions
    Commonwealth Fund · 2023–2023 · via The Johns Hopkins University
    22-23152
  • PI
    A national evaluation of Medicaid expansion on the prevention of child abuse and neglect, youth violence, and intimate partner violence
    NIH · 2018–2022 · via NIH RePORTER
    U01CE002947-03
  • PI
    Mental Health Services and Systems Training Program
    NIMH · 2017–2022 · via NIH RePORTER
    T32MH109436-05
  • PI
    An Evaluation of State Laws Intended to Curb High-Risk Opioid Prescribing
    NIDA · 2017–2022 · via NIH RePORTER
    R01DA044987-04
  • PI
    Improving Evidence-based Behavioral, Somatic and Social Service Delivery for SMI
    NIMH · 2015–2020 · via NIH RePORTER
    K01MH106631-04

Clinical research

5 studies
Completed & closed trials (5)
  • PI
    Influence of State Medicaid Section 1115 Waivers on Adolescent and Young Adult Substance Use Disorder Screening and Treatment
    Weill Medical College of Cornell University · CLOSED TO ACCRUAL (as of 2026)
  • PI
    The impact of peer support in treatment engagement and adverse events for Medicaid beneficiaries with substance use disorder
    Weill Medical College of Cornell University · CLOSED TO ACCRUAL (as of 2026)
  • PI
    Structure and Variability of State-level Medicaid Payment Rates
    Weill Medical College of Cornell University · IRB STUDY CLOSURE (as of 2026)
  • PI
    Medicaid payment policy: Landscape and opportunities for change
    Weill Medical College of Cornell University · CLOSED TO ACCRUAL (as of 2025)
  • PI
    Integrating Medicare and Medicaid for dual eligibles with serious mental illness: studying healthcare utilization, quality, and mortality
    Weill Medical College of Cornell University · CLOSED TO ACCRUAL (as of 2025)

News mentions

  • Commentary: AI Could Help to Implement Health Policy
    August 7, 2026

    Artificial intelligence may enhance implementation of a new federal rule requiring aduts enrolled under the Affordable Care Act expansion of Medicaid eligibility to complete qualifying work hours or community engagement activities or meet exemption criteria to maintain coverage, according to a new commentary.

  • Dr. Laura Riley to Unify Women’s Health Care Across Weill Cornell in New Role
    April 14, 2026

    As executive director for women’s health, a role that complements her position leading obstetrics and gynecology, Dr. Riley will unify, coordinate and drive new paradigms for women’s health care across medical specialties.

  • Reimagining Medicaid to Safeguard America’s Children
    April 9, 2026

    As states reassess Medicaid coverage following recent federal policy changes and the end of pandemic-era protections, researchers at Weill Cornell Medicine’s Department of Pediatrics, the Cornell Health Policy Center and Ariadne Labs are championing evidence-based health care policy reform and expanded Medicaid coverage for children.

  • Americans View Opioid Overdose as a Crisis that Needs to Be Addressed
    January 16, 2026

    Approximately 88% of adults view opioid overdose deaths as a very serious problem with high agreement across political groups, according to a national survey conducted by Weill Cornell Medicine researchers. However, political differences over who is responsible may shape the country’s next phase of drug policy.

  • Keeping Pediatrics Afloat in a Sea of Funding Cuts
    November 1, 2025

    As Medicaid funding cuts enacted through the One Big Beautiful Bill Act are expected to reduce health coverage among adults, researchers and clinicians warn that children are at increasing risk of unintended downstream effects.

Show 4 more mentions

External relationships

Advisory/Scientific Board Member

Dartmouth College

Professional Services

Washington University, The